Steve E. Krognes
Director · 5 filings · Latest: Jun 4, 2026
Denali Therapeutics Inc.
Guardant Health, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
GH | Steve E. Krognes | Director | Jun 4, 2026 | Sale | $132.51 | 9,294 | $1.2M | 10,222 | |
DNLI | Steve E. Krognes | Director | Jun 3, 2026 | Grant/Award | $0.00 | 6,408 | — | 38,202 | |
GH | Steve E. Krognes | Director | May 31, 2026 | Option Exercise | $0.00 | 154 | — | 19,516 | |
GH | Steve E. Krognes | Director | Apr 30, 2026 | Option Exercise | $0.00 | 154 | — | 19,362 | |
GH | Steve E. Krognes | Director | Mar 31, 2026 | Option Exercise | $0.00 | 155 | — | 19,208 |